Detalles de la búsqueda
1.
α-FAtE: A new predictive score of response to atezolizumab plus bevacizumab for unresectable hepatocellular carcinoma.
Int J Cancer
; 154(6): 1043-1056, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37994647
2.
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab.
Liver Int
; 44(5): 1108-1125, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38517286
3.
Role of the Prognostic Nutritional Index in Predicting Survival in Advanced Hepatocellular Carcinoma Treated with Atezolizumab Plus Bevacizumab.
Oncology
; 101(5): 283-291, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36657420
4.
Significance of ramucirumab following atezolizumab plus bevacizumab therapy for hepatocellular carcinoma using real-world data.
Hepatol Res
; 53(2): 116-126, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36316794
5.
The beneficial impact of metabolic dysfunction-associated fatty liver disease on lenvatinib treatment in patients with non-viral hepatocellular carcinoma.
Hepatol Res
; 53(2): 104-115, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36149726
6.
Telephone follow-up contributes to improving adherence and treatment duration in patients with hepatocellular carcinoma treated with lenvatinib.
J Gastroenterol Hepatol
; 38(7): 1140-1147, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-36880677
7.
Efficacy of Lenvatinib Combined with Transcatheter Intra-Arterial Therapies for Patients with Advanced-Stage of Hepatocellular Carcinoma: A Propensity Score Matching.
Int J Mol Sci
; 24(18)2023 Sep 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37762018
8.
[Minimally Invasive Conversion Hepatectomy for Advanced Hepatocellular Carcinoma].
Gan To Kagaku Ryoho
; 50(13): 1572-1574, 2023 Dec.
Artículo
en Japonés
| MEDLINE | ID: mdl-38303345
9.
[A case of difficult treatment of infected pseudoaneurysm of the femoral artery during hepatic arterial infusion chemotherapy for hepatocellular carcinoma].
Nihon Shokakibyo Gakkai Zasshi
; 120(3): 263-268, 2023.
Artículo
en Japonés
| MEDLINE | ID: mdl-36908145
10.
Multimolecular-Targeted Agents for Intermediate-Stage Hepatocellular Carcinoma Influence Time to Stage Progression and Overall Survival.
Oncology
; 99(12): 756-765, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34518483
11.
Adverse events as potential predictive factors of activity in patients with advanced hepatocellular carcinoma treated with lenvatinib.
Liver Int
; 41(12): 2997-3008, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34250737
12.
Increased Arterio-Portal Shunt Formation after Drug-Eluting Beads TACE for Hepatocellular Carcinoma.
Oncology
; 98(8): 558-565, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32422633
13.
Clinical utility of the Liver Frailty Index for predicting muscle atrophy in chronic liver disease patients with hepatocellular carcinoma.
Hepatol Res
; 50(3): 330-341, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31721387
14.
[A case of hemobilia due to the rupture of pancreaticoduodenal artery aneurysm with choledocholithiasis].
Nihon Shokakibyo Gakkai Zasshi
; 117(1): 92-98, 2020.
Artículo
en Japonés
| MEDLINE | ID: mdl-31941863
15.
Epirubicin is More Effective than Miriplatin in Balloon-Occluded Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma.
Oncology
; 96(2): 79-86, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30293080
16.
Dose and Location of Irradiation Determine Survival for Patients with Hepatocellular Carcinoma with Macrovascular Invasion in External Beam Radiation Therapy.
Oncology
; 96(4): 192-199, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-30650415
17.
Spontaneous regression of hepatocellular carcinoma with reduction in angiogenesis-related cytokines after treatment with sodium-glucose cotransporter 2 inhibitor in a cirrhotic patient with diabetes mellitus.
Hepatol Res
; 49(4): 479-486, 2019 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-30180287
18.
High serum interleukin-34 level is a predictor of poor prognosis in patients with non-viral hepatocellular carcinoma.
Hepatol Res
; 49(9): 1046-1053, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-30993774
19.
Slow walking speed overlapped with low handgrip strength in chronic liver disease patients with hepatocellular carcinoma.
Hepatol Res
; 49(12): 1427-1440, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31273895
20.
Prognostic impact of transcatheter arterial chemoembolization (TACE) combined with radiofrequency ablation in patients with unresectable hepatocellular carcinoma: Comparison with TACE alone using decision-tree analysis after propensity score matching.
Hepatol Res
; 49(8): 919-928, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-30969006